Precigen, Inc. (NASDAQ:PGEN ... related to FCX-007, a clinical stage product candidate developed by Castle Creek Biosciences, LLC, a portfolio company of Paragon, for the treatment of Epidermolysis ...
With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. So we asked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback